Christina Kay

Insider Reports History

Entity
Individual
Location
C/O 225 Long Avenue, Hillside, NJ
Signature
/s/ Christina Kay
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christina Kay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INTEGRATED BIOPHARMA INC Co-Chief Executive Officer, Director, 10%+ Owner Common Stock 1.33M $120K $0.09 Nov 25, 2024 Direct
INTEGRATED BIOPHARMA INC Co-Chief Executive Officer, Director, 10%+ Owner Stock Option (right to buy) 125K Dec 4, 2024 Direct

Insider Reports Filed by Christina Kay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INBP INTEGRATED BIOPHARMA INC Dec 4, 2024 1 $0 4 Dec 5, 2024 Co-Chief Executive Officer, Director, 10%+ Owner
INBP INTEGRATED BIOPHARMA INC Nov 25, 2024 2 $5K 4 Nov 25, 2024 Co-Chief Executive Officer, Director, 10%+ Owner
INBP INTEGRATED BIOPHARMA INC Nov 28, 2023 1 $0 4 Nov 29, 2023 Co-Chief Executive Officer, Director, 10%+ Owner
INBP INTEGRATED BIOPHARMA INC May 30, 2023 1 $17K 4 Jun 1, 2023 Co-Chief Executive Officer, Director
INBP INTEGRATED BIOPHARMA INC May 25, 2023 6 $1.37M 4 Sep 21, 2023 Co-Chief Executive Officer, Director, 10%+ Owner
INBP INTEGRATED BIOPHARMA INC Nov 9, 2022 1 $0 4 Nov 10, 2022 Co-Chief Executive Officer, Director
INBP INTEGRATED BIOPHARMA INC Nov 3, 2021 1 $0 4 Nov 3, 2021 Co-Chief Executive Officer, Director